Skip to main content
logo
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
68.33
+2.38 (3.61%)
At close: Oct 20, 2025, 4:00 PM EDT
67.81
-0.55 (-0.80%)
Pre-market: Oct 21, 2025, 4:55 AM EDT

PTC Therapeutics Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Collaboration
1.09B1.09B100.36M---150.08M--50.06M75.08M85.06M-55.05M--
Collaboration Growth
2,076.48%1,347.19%17.98%---172.60%---19.99%3.51%35.92%----
Net Product
561.88M576.77M600.95M601.31M609.92M651.30M661.25M633.70M
Net Product Growth
-7.88%-11.44%-9.12%-5.11%-2.23%9.84%23.55%20.33%
Royalty
213.57M209.15M203.86M196.70M185.51M169.18M168.86M157.73M--
Royalty Growth
15.13%23.63%20.73%24.71%32.05%34.85%48.74%66.14%--
Manufacturing
----5.00M7.06M7.69M------------

Revenue by Product

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Translarna
311.80M322.70M340.30M321.50M318.20M344.30M355.80M336.40M
Translarna Growth
-2.01%-6.27%-4.36%-4.43%-7.50%6.10%23.28%11.21%
Emflaza
186.30M197.20M206.70M224.10M239.60M258.00M255.10M245.80M
Emflaza Growth
-22.25%-23.57%-18.97%-8.83%2.74%15.02%16.86%18.34%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.